Cardinal Health Inc. announced a new debt offering involving the sale of two separate issuances. The company has entered into an underwriting agreement with Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC for the sale of $600 million in aggregate principal amount of its 4.500% Notes due 2030, and $400 million in aggregate principal amount of its 5.150% Notes due 2035. The offerings are being conducted under the company's effective registration statement on Form S-3ASR, previously filed with the Securities and Exchange Commission.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.